Michael E. Franklin
Impact in
- Transplantation top 5%
- Renal Transplantation Outcomes and Treatments
- Geriatrics and Gerontology top 5%
- Sirtuins and Resveratrol in Medicine
Papers in
-
- Renal Transplantation Outcomes and Treatments 6
-
- HIV/AIDS drug development and treatment 4
- Co-authors
- Paul J. Taylor (10 shared papers)Peter I. Pillans (5 shared papers)Graeme A. Macdonald (2 shared papers)Gary Cowin (1 shared paper)Jennifer Martin (1 shared paper)Ingrid J. Hickman (1 shared paper)Veronique Chachay (1 shared paper)Kerenaftali Klein (1 shared paper)
- Journals
- Journal of Chromatography B (3 papers)Therapeutic Drug Monitoring (3 papers)Clinical Biochemistry (2 papers)Journal of Pharmaceutical Sciences (1 paper)Liver International (1 paper)
- Partner nations
- AustraliaUnited KingdomDenmark
In The Last Decade
Michael E. Franklin
14 papers receiving 530 citations
Peers
Comparison fields: 5 of 83
- Transplantation 106
- Geriatrics and Gerontology 117
- Hepatology 49
- Epidemiology 175
- Hematology 52
Countries citing papers authored by Michael E. Franklin
This map shows the geographic impact of Michael E. Franklin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael E. Franklin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael E. Franklin more than expected).
Fields of papers citing papers by Michael E. Franklin
This network shows the impact of papers produced by Michael E. Franklin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael E. Franklin. The network helps show where Michael E. Franklin may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael E. Franklin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 244 | |
| 2 | 2012 | 55 | |
| 3 | 2010 | 50 | |
| 4 | 2018 | 30 | |
| 5 | 2010 | 29 | |
| 6 | 2010 | 27 | |
| 7 | 1991 | 27 | |
| 8 | 2011 | 24 | |
| 9 | 2006 | 23 | |
| 10 | 2010 | 12 | |
| 11 | 2010 | 11 | |
| 12 | 2023 | 6 | |
| 13 | 2021 | 4 | |
| 14 | The measurement of total and free mycophenolic acid by HPLC-Tandem mass spectrometry | 2007 | 1 |
About Michael E. Franklin
Michael E. Franklin is a scholar working on Transplantation, Infectious Diseases, Molecular Biology, Pediatrics, Perinatology and Child Health and Pharmacology, having authored 14 papers that have together received 543 indexed citations. Recurring topics across this work include Renal Transplantation Outcomes and Treatments (6 papers), HIV/AIDS drug development and treatment (4 papers), Pharmacological Effects and Toxicity Studies (2 papers), Antibiotics Pharmacokinetics and Efficacy (2 papers), Liver Disease Diagnosis and Treatment (2 papers), Biochemical and Molecular Research (2 papers), Human-Animal Interaction Studies (2 papers) and Pharmacovigilance and Adverse Drug Reactions (1 paper). The work is most often cited by research in Transplantation (106 citations), Geriatrics and Gerontology (117 citations), Hepatology (49 citations), Epidemiology (175 citations) and Hematology (52 citations). Michael E. Franklin has collaborated with scholars based in Australia, United Kingdom and Denmark. Frequent co-authors include Paul J. Taylor, Peter I. Pillans, Graeme A. Macdonald, Gary Cowin, Jennifer Martin, Ingrid J. Hickman, Veronique Chachay, Kerenaftali Klein, Johannes B. Prins and Paul P. Lee. Their work appears in journals such as Journal of Chromatography B, Therapeutic Drug Monitoring, Clinical Biochemistry, Journal of Pharmaceutical Sciences and Liver International.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.